SOS1- and KRAS-driven tumors
Part of Oncology
🏥1Companies
❤️1Engagements
Companies in SOS1- and KRAS-driven tumors
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Schrödinger
New York, New York, USA
Schrödinger is an international scientific software and biotechnology company, founded in 1990, developing computational tools for drug discovery and materials science. Its phys...
...moreBusiness ModelB2B (Software licensing) and a drug discovery model, advancing preclinical and clinical programs internally and through collaborations. SaaS is implied through platform licensing.
Core Techphysics-based computational platform
Funding$394.2M
Founded1990
Drug Discovery/Development
57
Related Companies
Semantically similar companies discovered by AI
N
New Cancer Treatment Technology
new cancer treatment, oxidative stress modulation in cancer cells,
Cancer
3
OncoLens
Atlanta, Georgia, US
A precision oncology solutions company.
Business ModelHybrid
Core TechAI/NLP
Funding$7.3M
Precision Medicine/Diagnostics
27
P
Proteome molecular profiling for discovery and diagnosis
Our technology reveals states, like cancerous or not, or drug responder or not. We do this by detecting many (10s of 1000s) of proteins and their variations and applying advance...
...morePrecision Medicine/Diagnostics
24